Although the presence of CHIP is one of the standard risk factors for the development of AML, CHIP expansion was found unlikely to be the mechanism underlying the increased incidence of MDS/AML among patients with MM [16]. This evidence concerns the gene STUB1 and Miyoshi myopathy.